Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 3
Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Recombinant Human Nerve Growth Factor Eye Drop Solution in Participants With Persistent Corneal Epithelial Defect (PCED)
This is a phase 3, randomized, multicenter, double-masked, parallel group, vehicle-controlled prospective clinical trial to evaluate the safety and efficacy of…
Persistent Corneal Epithelial Defect
Estimated
~$10 – $7,500
Dompé Farmaceutici S.p.ANCT07519902
Phase 2
A Randomized, Multicenter, Double-Masked, Vehicle-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With Persistent Corneal Epithelial Defects (NEXPEDE-1)
This study is to evaluate the safety and efficacy of NEXAGON® (lufepirsen ophthalmic gel) (NEXAGON) in subjects with persistent corneal epithelial defects (PCE…
Persistent Corneal Epithelial Defect
Estimated
~$10 – $8,750
Glaukos CorporationNCT05966493
Phase 2
Phase II Study of the Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
In this phase II randomized double-masked clinical trials, subjects with non-resolving corneal epithelial disease/defect (i.e., refractory to standard treatmen…
Persistent Corneal Epithelial DefectCorneal Epithelial Disorders
Estimated
~$10 – $6,250
University of Illinois at ChicagoNCT06919081